ZFP82 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.817900E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.058800E-01
Normal-vs-Stage2
1.188550E-04
Normal-vs-Stage3
5.733600E-02
Normal-vs-Stage4
2.304000E-01
Stage1-vs-Stage2
2.032800E-01
Stage1-vs-Stage3
2.284600E-01
Stage1-vs-Stage4
6.899400E-01
Stage2-vs-Stage3
6.824400E-01
Stage2-vs-Stage4
2.762600E-01
Stage3-vs-Stage4
4.446200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.022100E-04
Normal-vs-AfricanAmerican
6.190400E-02
Normal-vs-Asian
4.995200E-03
Caucasian-vs-AfricanAmerican
4.724800E-01
Caucasian-vs-Asian
3.320200E-01
AfricanAmerican-vs-Asian
2.038600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.221400E-04
Normal-vs-Female
1.682240E-03
Male-vs-Female
8.545900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.807600E-01
Normal-vs-Age(41-60Yrs)
1.955260E-03
Normal-vs-Age(61-80Yrs)
3.002200E-04
Normal-vs-Age(81-100Yrs)
2.464200E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.474500E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.093600E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.037100E-03
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.876780E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.201200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.807600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.422480E-04
Normal-vs-Daily Drinker
1.778210E-03
Normal-vs-Weekly Drinker
6.079000E-03
Normal-vs-Occasional Drinker
9.224900E-03
Normal-vs-Social Drinker
1.294130E-02
Non Drinker-vs-Daily Drinker
6.722400E-01
Non Drinker-vs-Weekly Drinker
3.228200E-01
Non Drinker-vs-Occasional Drinker
3.544800E-01
Non Drinker-vs-Social Drinker
2.504200E-01
Daily Drinker-vs-Weekly Drinker
6.019400E-01
Daily Drinker-vs-Occasional Drinker
6.354400E-01
Daily Drinker-vs-Social Drinker
4.986200E-01
Weekly Drinker-vs-Occasional Drinker
9.701600E-01
Weekly Drinker-vs-Social Drinker
8.705000E-01
Occasional Drinker-vs-Social Drinker
8.457600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.324600E-01
Normal-vs-Grade 2
1.862240E-01
Normal-vs-Grade 3
2.447400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.445600E-01
Grade 1-vs-Grade 3
1.595230E-01
Grade 1-vs-Grade 4
2.324600E-01
Grade 2-vs-Grade 3
3.990200E-01
Grade 2-vs-Grade 4
1.862240E-01
Grade 3-vs-Grade 4
2.447400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.208600E-04
Normal-vs-NonDiabetic
3.165400E-04
Diabetic-vs-NonDiabetic
9.501200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.078900E-03
Normal-vs-NoPancreatitis
1.820410E-04
Pancreatitis-vs-NoPancreatitis
3.868600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.244160E-03
Normal-vs-N1
2.832600E-04
N0-vs-N1
7.726200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.407010E-01
Normal-vs-TP53-NonMutant
2.282200E-02
TP53-Mutant-vs-TP53-NonMutant
4.217500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
